Duration: (5:1econd) ?Subscribe5835 2025-02-27T23:32:20+00:00
FDA D.I.S.C.O.: FDA approval of cabozantinib for hepatocellular carcinoma
(5:31)
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
(6:1econd)
FDA D.I.S.C.O. Burst Edition: FDA approvals of Rituxan (rituximab) plus chemotherapy for pediatri...
(7:1econd)
FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia
(5:1econd)
FDA D.I.S.C.O. Burst Edition: Lorbrena (lorlatinib) for patients with metastatic non-small cell l...
(4:1econd)
FDA D.I.S.C.O.: First FDA approval of a CAR T-cell immunotherapy
FDA D.I.S.C.O. Burst Edition: FDA approval of Tibsovo (ivosidenib) for patients with relapsed or ...
(3:31)
FDA D.I.S.C.O.: A new drug approval for non-metastatic castration-resistant prostate cancer
Jigar Da Tukda - Full Song | Ladies vs Ricky Bahl | Ranveer Singh | Parineeti Chopra
(4:20)
Advancing the Use of Complex Innovative Designs in Clinical Trials: From Pilot to Practice - Part 1
(2:22:40)
FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)
(4:38:30)
January 10, 2025 Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) Meeting
(7:49:20)
IFA Wartburg - The free German youth / IFA Wartburg - Freie Deutsche Jugend (FDJ)
(4:37)
FDA to Redefine “Healthy” Food
(4:10)
An Overview of FDA's Project Facilitate Oncology Expanded Access Program
(50:9)
Freestyle Disco Norway Feb 2010
(6:42)
Navigating FDA's Drug Information Resources
(50:52)
FDA Drug Topics - FDA Drug Information Resources and Applicability to Health Care Professionals
(52:15)
FDA D.I.S.C.O.: Intro by Dr. Richard Pazdur
(3:21)
FDA D.I.S.C.O. Burst Edition: FDA approvals of Retevmo (selpercatinib) for adult patients with lo...
(6:31)
FDA D.I.S.C.O.: First biosimilar approval for the treatment of cancer
(8:31)
FDA D.I.S.C.O. Burst Edition: FDA approval of Omisirge (omidubicel-onlv) to reduce time to neutro...
FDA D.I.S.C.O. Burst Edition: FDA approval of Polivy (polatuzumab vedotin-piiq) for previously un...
FDA D.I.S.C.O. Burst Edition: FDA approval of Rezurok (belumosudil) for adult and pediatric patie...
FDA D.I.S.C.O.: A new drug approval for IDH1 positive relapsed or refractory Acute Myeloid Leukemia
FDA D.I.S.C.O. Burst Edition: FDA approval of Tibsovo (ivosidenib) for adult patients with previo...
(3:1econd)
FDA D.I.S.C.O. Burst Edition: FDA approvals of Jemperli (dostarlimab-gxly) for adults with mismat...
FDA D.I.S.C.O. Burst Edition: FDA approves Rylaze (asparaginase erwinia chrysanthemi (recombinant...
FDA D.I.S.C.O. Burst Edition: FDA approval of Ryoncil (remestemcel-L-rknd) for steroid-refractory...